🔗 Share this article

A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Followers are encouraged to contact these profiles privately for source information, while also receiving promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing trade exists on messaging services, where communities with thousands of participants share “before and after” photos, injection guides and assertions of rapid British shipping. Sellers market the substance there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Concerns

However, physicians and pharmacists have cautions that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to users injecting products of uncertain source.

Some professionals said the popularity for the experimental drug could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unapproved medication that cannot be promoted or supplied for personal consumption under the British medical regulations.

Several content creators try to circumvent the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to penalties, legal action or prison.

Service Response and Content Removal

Based on TikTok, the platform has taken down violative content and banned related keywords and query recommendations. The organization said it was dedicated to keeping the service safe and investing in strengthening enforcement strategies.

Online Trading Activities

Research also found groups with up to 9,000 participants selling the experimental drug using Telegram's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly displays channels with numerous of members, filled with images of weight loss, positive testimonials and detailed guides for mixing or administering at residence.

After minutes of joining one group, a vendor posted WhatsApp details, where most purchases take place. The vendor sent an guidebook and guaranteed delivery within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or previous experience.

Item Details and Pricing

Inside these communities, posts show black plastic packages with Royal Mail labels, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors typically sold at £160 for 20 milligrams. When questioned how much time a injector should last, sellers give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for the messaging service stated it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are injecting materials they cannot confirm. Although the science behind this drug is sound, these online versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor linked the surge in demand to current cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, individuals are using social media. But fake treatments are extremely risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen patients harmed by self-injection from unconfirmed suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your health,” stated the doctor. “These substances could be contaminated or incorrectly dosed.”

Manufacturer Statement

A spokesperson from Eli Lilly stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority globally. “Therefore at this point no one can market [it] for personal consumption,” they explained, noting that any product “falsely representing itself as a company experimental product not yet authorized … may subject patients to potentially significant medical dangers”.